Sign in

CIK 0001869105 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

BridgeBio Oncology Therapeutics, Inc.

Sign in to watch
Ticker
BBOT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
857 702 0377
Business address
256 E. GRAND AVENUE, SUITE 104, SOUTH SAN FRANCISCO, CA, 94080
Former names
Helix Acquisition Corp. II
  1. 8-K Event Regulation FD disclosure
  2. EFFECT Other Notice of Effectiveness
  3. 424B4 Offering Prospectus
  4. CORRESP Other Correspondence Between Filers and SEC Staff
  5. S-4/A Deal Registration Statement - Business Combination
  6. CORRESP Other Correspondence Between Filers and SEC Staff
  7. S-4/A Deal Registration Statement - Business Combination
  8. UPLOAD Other SEC-generated Letter
  9. CORRESP Other Correspondence Between Filers and SEC Staff
  10. S-4 Deal Registration Statement - Business Combination
  11. UPLOAD Other SEC-generated Letter
  12. DRSLTR Other Correspondence Related to Draft Registration Statement
  13. DRS/A Other Draft Registration Statement
  14. 10-Q Report Quarterly Report
  15. UPLOAD Other SEC-generated Letter
  16. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  17. SCHEDULE 13G Stake Statement of Beneficial Ownership
  18. DRS Other Draft Registration Statement
  19. DRSLTR Other Correspondence Related to Draft Registration Statement
  20. 10-K Report Annual Report

Page 7 of 10 · 187 filings